Greg Versmee

Greg Versmee, MD, MBA, is currently the Early Clinical Development Lead for Oncology Hematology at Johnson & Johnson. Prior to this, they held various prominent roles, including Director of R&D Clinical Trial Data Strategy & Transformation at Takeda and Associate Director of Medical Informatics at Pfizer. Greg's extensive experience also includes serving as a Postdoctoral Research Fellow at Harvard Medical School, where they significantly contributed to a large NIH project, and as an Attending Emergency Physician at Bordeaux University Hospital. They are pursuing advanced degrees in medicine and public health while maintaining a strong focus on integrating data science with clinical research and development.